Advertisement

Liver Tumor I: Benign Tumors and Tumor-Like Lesions

  • Wilson M. S. TsuiEmail author
  • Takahiro Mori
  • Masaki Iwai
Chapter

Abstract

Compared to malignant tumors, benign tumors of the liver are encountered rarely in daily practice, although their true incidence is probably not low [1]. This is because they are either asymptomatic and not discovered or they are not biopsied and left unresected. However, ultrasonographic imaging often may show benign tumors in the liver. Some of these tumors are true neoplasms, while others are tumor-like masses (Table 16.1) [2].

Abbreviations

AFP

Alpha-fetoprotein

AML

Angiomyolipoma

BDA

Bile duct adenoma

CEA

Carcinoembryonic antigen

c-myc

Cancer-myelocytomatosis

ELISA

Enzyme-linked immunosorbent assay

FNH

Focal nodular hyperplasia

HCA

Hepatocellular adenoma

HCC

Hepatocellular carcinoma

HMB45

Human melanoma black 45

HNF-1

Hepatocyte nuclear factor 1

IL6ST

Interleukin 6 signal transducer

IPN

Intraductal papillary neoplasm

IPT

Inflammatory pseudotumor

L-FABP

Liver fatty acid binding protein

LMS

Larva migrans syndrome

MCN

Mucinous cystic neoplasm

p53

53-kilodalton protein

PECOMA

Perivascular epithelioid cell tumors

PIVKA2

Protein induced by vitamin K absence or antagonist-2

Notes

Acknowledgment

Prof. Alex Y. Chang was a coauthor of the first edition of this chapter.

References

  1. 1.
    Goodman ZD. Benign tumors of the liver. In: Okuda K, Ishak KG, editors. Neoplasms of the liver. Berlin: Springer; 1988. p. 105–25.Google Scholar
  2. 2.
    Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system. 4th ed. Lyon: International Agency for Research on Cancer; 2010.Google Scholar
  3. 3.
    Shimizu M, Miura J, Itoh H, Saitoh Y. Hepatic giant cavernous hemangioma with microangiopathic hemolytic anemia and consumption coagulopathy. Am J Gastroenterol. 1990;85:1411–3.PubMedGoogle Scholar
  4. 4.
    Kim GE, Thung SN, Tsui WM, Ferrell LD. Hepatic cavernous hemangioma: underrecognized associated histologic features. Liver Int. 2006;26:334–8.CrossRefGoogle Scholar
  5. 5.
    Lehmann FS, Beglinger C, Schnabel K, Terraciano L. Progressive development of diffuse liver angiomatosis. J Hepatol. 1999;30:951–4.CrossRefGoogle Scholar
  6. 6.
    Ryan RM, Buelow B, Mather C, et al. Hepatic small vessel neoplasm, a rare infiltrative vascular neoplasm of uncertain malignant potential. Hum Pathol. 2016;54:143–51.CrossRefGoogle Scholar
  7. 7.
    Song JS, Kim YN, Moon WS. A sclerosing hemangioma of the liver. Clin Mol Hepatol. 2013;19:426–30.CrossRefGoogle Scholar
  8. 8.
    Yamashita Y, Shimada M, Taguchi K, Gion T, Hasegawa H, Utsunomiya T, et al. Hepatic sclerosing hemangioma mimicking a metastatic liver tumor: report of a case. Surg Today. 2000;30:849–52.CrossRefGoogle Scholar
  9. 9.
    Lee VT, Magnaye M, Tan HW, Thng CH, Ooi LL. Sclerosing haemangioma mimicking hepatocellular carcinoma. Singap Med J. 2005;46:140–3.Google Scholar
  10. 10.
    Makhlouf HR, Ishak KG. Sclerosed hemangioma and sclerosing cavernous hemangioma of the liver: a comparative clinicopathologic and immunohistochemical study with emphasis on the role of mast cells in their histogenesis. Liver. 2002;22:70–8.CrossRefGoogle Scholar
  11. 11.
    Stocker JT, Ishak KG. Focal nodular hyperplasia of the liver: a study of 21 pediatric cases. Cancer. 1981;48:336–45.CrossRefGoogle Scholar
  12. 12.
    Paradis V, Laurent A, Flejou JF, Vidaud M, Bedossa P. Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X chromosome inactivation. Hepatology. 1997;26:891–5.CrossRefGoogle Scholar
  13. 13.
    Wanless I, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology. 1985;5:1194–200.CrossRefGoogle Scholar
  14. 14.
    Nguyen BN, Fléjou JF, Terris B, Belghiti J, Degott C. Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol. 1999;23:1441–54.CrossRefGoogle Scholar
  15. 15.
    Paradis V, Benzekri A, Dargère D, Bièche I, Laurendeau I, Vilgrain V, et al. Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology. 2004;126:1323–9.CrossRefGoogle Scholar
  16. 16.
    Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology. 2006;43:515–24.CrossRefGoogle Scholar
  17. 17.
    Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Sa Cunha A, Rullier A, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 2007;46:740–8.CrossRefGoogle Scholar
  18. 18.
    Govindarajan S, Peters RL. The bile duct adenoma. A lesion distinct from Meyenburg complex. Arch Pathol Lab Med. 1984;108:922–4.PubMedGoogle Scholar
  19. 19.
    Allaire GS, Rabin L, Ishak KG, Sesterhenn IA. Bile duct adenoma: a study of 152 cases. Am J Surg Pathol. 1988;12:708–15.CrossRefGoogle Scholar
  20. 20.
    Bhathal PS, Hughes NR, Goodman ZD. The so-called bile duct adenoma is a peribiliary gland hamartoma. Am J Surg Pathol. 1996;20:858–64.CrossRefGoogle Scholar
  21. 21.
    Colombari R, Tsui WM. Biliary tumors of the liver. Semin Liver Dis. 1995;15:402–13.CrossRefGoogle Scholar
  22. 22.
    Tsui WM, Loo KT, Chow LT, Tse CC. Biliary adenofibroma. A heretofore unrecognized benign biliary tumor of the liver. Am J Surg Pathol. 1993;17:186–92.CrossRefGoogle Scholar
  23. 23.
    Varnholt H, Vauthey JN, Dal Cin P, Marsh Rde W, Bhathal PS, Hughes NR, et al. Biliary adenofibroma: a rare neoplasm of bile duct origin with an indolent behavior. Am J Surg Pathol. 2003;27:693–8.CrossRefGoogle Scholar
  24. 24.
    Arnason T, Borger DR, Corless C, Hagen C, Iafrate AJ, Makhlouf H, Misdraji J, Sapp H, Tsui WM, Wanless IR, Zuluaga Toro T, Lauwers GY. Biliary adenofibroma of liver: morphology, tumor genetics, and outcomes in 6 cases. Am J Surg Pathol. 2017;41:499–505.CrossRefGoogle Scholar
  25. 25.
    Thai E, Dalla Valle R, Evaristi F, Silini EM. A case of biliary adenofibroma with malignant transformation. Pathol Res Pract. 2016;212:468–70.CrossRefGoogle Scholar
  26. 26.
    Thompson SM, Zendejas-Mummert B, Hartgers ML, Venkatesh SK, Smyrk TC, Mahipal A, Smoot RL. Malignant transformation of biliary adenofibroma: a rare biliary cystic tumor. J Gastrointest Oncol. 2016;7:E107–12.CrossRefGoogle Scholar
  27. 27.
    Albores-Saavedra J, Hoang MP, Murakata LA, Sinkre P, Yaziji H. Atypical bile duct adenoma, clear cell type: a previously undescribed tumor of the liver. Am J Surg Pathol. 2001;25:956–60.CrossRefGoogle Scholar
  28. 28.
    Ishak KG, Willis GW, Cummins SD, Bullock AA. Biliary cystadenoma and cystadenocarcinoma: report of 14 cases and review of the literature. Cancer. 1977;39:322–38.CrossRefGoogle Scholar
  29. 29.
    Wheeler DA, Edmondson HA. Cystadenoma with mesenchymal stroma (CMS) in the liver and bile ducts. A clinicopathologic study of 17 cases, 4 with malignant change. Cancer. 1985;56:1434–45.CrossRefGoogle Scholar
  30. 30.
    Devaney K, Goodman ZD, Ishak KG. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol. 1994;18:1078–91.CrossRefGoogle Scholar
  31. 31.
    Subramony C, Herrera GA, Turbat-Herrera EA. Hepatobiliary cystadenoma. A study of five cases with reference to histogenesis. Arch Pathol Lab Med. 1993;117:1036–42.PubMedGoogle Scholar
  32. 32.
    Terada T, Kitamura Y, Ohta T, Nakanuma Y. Endocrine cells in hepatobiliary cystadenomas and cystadenocarcinomas. Virchows Arch. 1997;430:37–40.CrossRefGoogle Scholar
  33. 33.
    Kim YI, Kim ST, Lee GK, Choi BI. Papillary cystic tumor of the liver. Cancer. 1990;65:2740–6.CrossRefGoogle Scholar
  34. 34.
    Nakanuma Y, Sasaki M, Terada T, Harada K. Intrahepatic peribiliary glands of humans. II. Pathological spectrum. J Gastroenterol Hepatol. 1994;9:80–6.CrossRefGoogle Scholar
  35. 35.
    Madden JJ Jr, Smith GW. Multiple biliary papillomatosis. Cancer. 1974;34:1316–20.CrossRefGoogle Scholar
  36. 36.
    Chen TC, Nakanuma Y, Zen Y, Chen MF, Jan YY, Yeh TS, et al. Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology. 2001;34:651–8.CrossRefGoogle Scholar
  37. 37.
    Kim YS, Myung SJ, Kim SY, Kim HJ, Kim JS, Park ET, et al. Biliary papillomatosis: clinical, cholangiographic and cholangioscopic findings. Endoscopy. 1998;30:763–7.CrossRefGoogle Scholar
  38. 38.
    Tsui WM, Lam PW, Mak CK, Pay KH. Fine-needle aspiration cytologic diagnosis of intrahepatic biliary papillomatosis (intraductal papillary tumor): report of three cases and comparative study with cholangiocarcinoma. Diagn Cytopathol. 2000;22:293–8.CrossRefGoogle Scholar
  39. 39.
    Nakanuma Y, Sasaki M, Ishikawa A, Tsui W, Chen TC, Huang SF. Biliary papillary neoplasm of the liver. Histol Histopathol. 2002;17:851–61.PubMedGoogle Scholar
  40. 40.
    Rambaud S, Nores JM, Meeus F, Paolaggi JA. Malignant papillomatosis of the bile ducts: a new indication for liver transplantation? Am J Gastroenterol. 1989;84:448–9.PubMedGoogle Scholar
  41. 41.
    Goodman ZD, Ishak KG. Angiomyolipomas of the liver. Am J Surg Pathol. 1984;8:745–50.CrossRefGoogle Scholar
  42. 42.
    Nonomura A, Mizukami Y, Kadoya M, Matsui O, Shimizu K, Izumi R. Angiomyolipoma of the liver: a collective review. J Gastroenterol. 1994;29:95–105.CrossRefGoogle Scholar
  43. 43.
    Tsui WM, Colombari R, Portmann BC, Bonetti F, Thung SN, Ferrell LD, et al. Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol. 1999;23:34–48.CrossRefGoogle Scholar
  44. 44.
    Bonetti F, Pea M, Martignoni G, Zamboni G. The perivascular epithelioid cell and related lesions. Adv Anat Pathol. 1997;4:343–58.CrossRefGoogle Scholar
  45. 45.
    Nguyen TT, Gormann B, Shileds D, Goodman Z. Malignant hepatic angiomyolipoma: report of case and review of literature. Am J Surg Pathol. 2008;32:793–8.CrossRefGoogle Scholar
  46. 46.
    Anthony PP, Telesinghe PU. Inflammatory pseudotumour of the liver. J Clin Pathol. 1986;39:761–8.CrossRefGoogle Scholar
  47. 47.
    Horiuchi R, Uchida T, Kojima T, Shikata T. Inflammatory pseudotumor of the liver. Clinicopathologic study and review of the literature. Cancer. 1990;65:1583–90.CrossRefGoogle Scholar
  48. 48.
    Shek TW, Ng IO, Chan KW. Inflammatory pseudotumor of the liver. Report of four cases and review of the literature. Am J Surg Pathol. 1993;17:231–8.CrossRefGoogle Scholar
  49. 49.
    Zen Y, Harada K, Sasaki M, Sato Y, Tsuneyama K, Haratake J, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol. 2004;28:1193–203.CrossRefGoogle Scholar
  50. 50.
    Zen Y, Fujii T, Sato Y, Masuda S, Nakanuma Y. Pathological classification of hepatic inflammatory pseudotumor, with respect to IgG4-related disease. Mod Pathol. 2007;20:884–94.CrossRefGoogle Scholar
  51. 51.
    Selves J, Meggetto F, Brousset P, Voigt JJ, Pradère B, Grasset D, et al. Inflammatory pseudotumor of the liver. Evidence for follicular dendritic reticulum cell proliferation associated with clonal Epstein-Barr virus. Am J Surg Pathol. 1996;20:747–53.CrossRefGoogle Scholar
  52. 52.
    Su LD, Atayde-Perez A, Sheldon S, Fletcher JA, Weiss SW. Inflammatory myofibroblastic tumor: cytogenetic evidence supporting clonal origin. Mod Pathol. 1998;11:364–8.PubMedGoogle Scholar
  53. 53.
    Gonzalez-Ojeda A, Rodriguez-Alcantar DA, Arenas-Marquez H, Sanchez Perez-Verdia E, Chavez-Perez R, Alvarez-Quintero R, et al. Retained foreign bodies following intra-abdominal surgery. Hepatogastroenterology. 1999;46:808–12.PubMedGoogle Scholar
  54. 54.
    Kalovidouris A, Kehagias D, Moulopoulos L, Gouliamos A, Pentea S, Vlahos L. Abdominal retained surgical sponges: CT appearance. Eur Radiol. 1999;9:1407–10.CrossRefGoogle Scholar
  55. 55.
    Shepherd NA, Lee G. Solitary necrotic nodules of the liver simulating hepatic metastases. J Clin Pathol. 1983;36:1181–3.CrossRefGoogle Scholar
  56. 56.
    Berry CL. Solitary “necrotic nodule” of the liver: a probable pathogenesis. J Clin Pathol. 1985;38:1278–80.CrossRefGoogle Scholar
  57. 57.
    Sundaresan M, Lyons B, Akosa AB. “Solitary” necrotic nodules of the liver: an aetiology reaffirmed. Gut. 1991;32:1378–80.CrossRefGoogle Scholar
  58. 58.
    Tsui WM, Yuen RW, Chow LT, Tse CC. Solitary necrotic nodule of the liver: parasitic origin? J Clin Pathol. 1992;45:975–8.CrossRefGoogle Scholar
  59. 59.
    Feldmeier H, Schuster A. Mini review: hookworm-related cutaneous larva migrans. Eur J Clin Microbiol Infect Dis. 2012;31:915–8.CrossRefGoogle Scholar
  60. 60.
    Liu Q, Li MW, Wang ZD, Zhao GH, Zhu XQ. Human sparganosis, a neglected food borne zoonosis. Lancet Infect Dis. 2015;15:1226–35.CrossRefGoogle Scholar
  61. 61.
    Macpherson CN. The epidemiology and public health importance of toxocariasis: a zoonosis of global importance. Int J Parasitol. 2013;43:999–1008.CrossRefGoogle Scholar
  62. 62.
    Maruyama H, Nawa Y, Noda S, Mimori T, Choi WY. An outbreak of visceral larva migrans due to Ascaris suum in Kyushu, Japan. Lancet. 1996;347:1766–7.CrossRefGoogle Scholar
  63. 63.
    Despommier D. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev. 2003;16:265–72.CrossRefGoogle Scholar
  64. 64.
    Pinelli E, Herremans T, Harms MG, Hoek D, Kortbeek LM. Toxocara and Ascaris seropositivity among patients suspected of visceral and ocular larva migrans in the Netherlands: trends from 1998 to 2009. Eur J Clin Microbiol Infect Dis. 2011;30:873–9.CrossRefGoogle Scholar
  65. 65.
    Baldisserotto M, Conchin CF, Soares Mda G, Araujo MA, Kramer B. Ultrasound findings in children with toxocariasis: report on 18 cases. Pediatr Radiol. 1999;29:316–9.CrossRefGoogle Scholar
  66. 66.
    Ishibashi H, Shimamura R, Hirata Y, Kudo J, Onizuka H. Hepatic granuloma in toxocaral infection: role of ultrasonography in hypereosinophilia. J Clin Ultrasound. 1992;20:204–10.CrossRefGoogle Scholar
  67. 67.
    Parsons JC, Bowman DD, Grieve RB. Tissue localization of excretory-secretory antigens of larval Toxocara canis in acute and chronic murine toxocariasis. Am J Trop Med Hyg. 1986;27:492–8.Google Scholar
  68. 68.
    Kaplan KJ, Goodman ZD, Ishak KG. Eosinophilic granuloma of the liver: a characteristic lesion with relationship to visceral larva migrans. Am J Surg Pathol. 2001;25:1316–21.CrossRefGoogle Scholar
  69. 69.
    de Savigny DH, Volle A, Woodruff AW. Toxocariasis: serological diagnosis by enzyme immunoassay. J Clin Pathol. 1979;32:284–8.CrossRefGoogle Scholar
  70. 70.
    Magnaval JF, Fabre R, Maurieres P, Charlet JP, de Larrard B. Application of the western blotting procedure for the immunodiagnosis of human toxocariasis. Parasitol Res. 1991;77:697–702.CrossRefGoogle Scholar
  71. 71.
    Khuroo MS. Ascariasis. Gastroenterol Clin North Am. 1996;25:553–77.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Wilson M. S. Tsui
    • 1
    Email author
  • Takahiro Mori
    • 2
  • Masaki Iwai
    • 3
  1. 1.Hong KongChina
  2. 2.HyogoJapan
  3. 3.KyotoJapan

Personalised recommendations